PMID: 7538178Jun 1, 1995Paper

Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies

Journal of Virology
H ZhangR J Pomerantz

Abstract

Reverse transcription of retroviral genomic RNA in a target cell is influenced by cellular factors, including the concentration of deoxyribonucleoside triphosphates (dNTPs). In addition, recent data have demonstrated that reverse transcription can be driven within human immunodeficiency virus type 1 virions, prior to infection of a cell, by increasing extracellular concentrations of dNTPs. In attempts to increase the transduction efficiency of recombinant murine leukemia virus vectors, endogenous reverse transcription was initiated within cell-free, recombinant murine leukemia virus virions in the presence of relatively high concentrations of dNTPs. As a result, the expression of transduced genes via these retroviral vectors was increased approximately 10-fold by treatment of virions with dNTPs. Combined with our previous data, these observations suggest that virion-associated DNA synthesis can occur in diverse groups of retroviruses and positively alter retroviral infectivity. As such, these manipulations may be useful for increasing the efficiency of retrovirus-mediated gene delivery.

References

Jan 1, 1975·Journal of Virology·E Rothenberg, D Baltimore
Nov 1, 1979·Journal of Cellular Physiology·M Anwar WaqarJ A Huberman
Feb 10, 1975·Biochimica Et Biophysica Acta·S SekiG C Mueller
Aug 11, 1992·Journal of Virology·F LoriR C Gallo
Apr 1, 1989·Genes & Development·B BowermanH E Varmus
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R C AloiaL M Gordon
Aug 1, 1986·Molecular and Cellular Biology·A D Miller, C Buttimore
Jun 27, 1970·Nature·H M Temin, S Mizutani
Sep 1, 1982·Molecular and Cellular Biology·C M GormanB H Howard
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M I BukrinskyM Stevenson
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W Y GaoF Lori
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R C AloiaF C Jensen

❮ Previous
Next ❯

Citations

Feb 12, 2008·Current Protocols in Molecular Biology·W Pear
Oct 16, 2016·Oncotarget·Joanna D NowackaManuela Baccarini
Jan 1, 1997·Stem Cells·M HavengaH H van Es
Oct 31, 2000·Current Opinion in Hematology·M SadelainI Rivière

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.